Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuvanan Ray

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Minerva Cardiology and Angiology|September 2, 2021
Nano-crush technique in narrow-angle (<70°) bifurcation: bench test, CT reconstruction, fluid dynamics, and clinical outcomesShuvanan Ray, Siddhartha Bandyopadhyay, Prithwiraj Bhattacharjee, et al.
Indian Heart Journal|February 21, 2016
Angioplasty of unprotected left main coronary stenosis: Real world experience of a single-operator group from eastern IndiaShuvanan Ray, Alok Mazumder, Soumitra Kumar, et al.
BMJ Open Respiratory Research|September 23, 2020
Two chair test: a substitute of 6 min walk test appear cardiopulmonary reserve specificParthasarathi Bhattacharyya, Dipanjan Saha, Mintu Paul, et al.
International Journal of Cardiology. Heart & Vasculature|November 6, 2024
Breaking boundaries: Ticagrelor monotherapy in high-risk patientsBalbir Singh, D Prabhakar, Jay Shah, et al.
Minerva Cardiology and Angiology|February 25, 2022
Twelve-month clinical outcomes of "nano-crush technique" for the treatment of bifurcation lesions using ultra-thin (60 µm) sirolimus-eluting coronary stentsSantosh K Sinha, Prakash Kumar, Umeshwar Pandey, et al.
Indian Heart Journal|January 31, 2015
Safety of Prasugrel in Indian patients - multicentric registry of 1000 casesUpendra Kaul, Arvind Sethi, P Arambam, et al.
The Journal of the Association of Physicians of India|November 16, 2021
Expert Opinion on P2Y12 Inhibitors Use in Management of Acute Coronary Syndromes: Focus on TicagrelorImmaneni Sathyamurthy, M S Hiremath, Jitendra Pal Sawhney, et al.
Asiaintervention|March 21, 2025
Long-term safety and performance of the BioMime Morph sirolimus-eluting coronary stent system for very long coronary lesions in real-world settingsDeepak Davidson, Mukul Misra, Sharad Chandra, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Minerva Cardiology and Angiology|September 2, 2021
Nano-crush technique in narrow-angle (<70°) bifurcation: bench test, CT reconstruction, fluid dynamics, and clinical outcomesShuvanan Ray, Siddhartha Bandyopadhyay, Prithwiraj Bhattacharjee, et al.
Indian Heart Journal|February 21, 2016
Angioplasty of unprotected left main coronary stenosis: Real world experience of a single-operator group from eastern IndiaShuvanan Ray, Alok Mazumder, Soumitra Kumar, et al.
BMJ Open Respiratory Research|September 23, 2020
Two chair test: a substitute of 6 min walk test appear cardiopulmonary reserve specificParthasarathi Bhattacharyya, Dipanjan Saha, Mintu Paul, et al.
International Journal of Cardiology. Heart & Vasculature|November 6, 2024
Breaking boundaries: Ticagrelor monotherapy in high-risk patientsBalbir Singh, D Prabhakar, Jay Shah, et al.
Minerva Cardiology and Angiology|February 25, 2022
Twelve-month clinical outcomes of "nano-crush technique" for the treatment of bifurcation lesions using ultra-thin (60 µm) sirolimus-eluting coronary stentsSantosh K Sinha, Prakash Kumar, Umeshwar Pandey, et al.
Indian Heart Journal|January 31, 2015
Safety of Prasugrel in Indian patients - multicentric registry of 1000 casesUpendra Kaul, Arvind Sethi, P Arambam, et al.
The Journal of the Association of Physicians of India|November 16, 2021
Expert Opinion on P2Y12 Inhibitors Use in Management of Acute Coronary Syndromes: Focus on TicagrelorImmaneni Sathyamurthy, M S Hiremath, Jitendra Pal Sawhney, et al.
Asiaintervention|March 21, 2025
Long-term safety and performance of the BioMime Morph sirolimus-eluting coronary stent system for very long coronary lesions in real-world settingsDeepak Davidson, Mukul Misra, Sharad Chandra, et al.
Pageof 2